Glutamine reduces the expression of leukocyte integrins leukocyte function-associated antigen-1 and macrophage antigen-1 in mice exposed to arsenic

Nutrition Research

Volumn 28, Issue 8, 2008, Pages 544-549

  Pai, Man Hui ^a   Chien, Yi Wen ^a   Tsai, Ya Hui ^a   Hu, Ya Mei ^a   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Glutamine; Interferon ; Interleukin 4; Interleukin 6; Leukocyte function associated antigen 1; Macrophage antigen 1; Mice; tumor necrosis factor

Indexed keywords

ARSENATE SODIUM; BETA INTEGRIN; GAMMA INTERFERON; GLUTAMINE; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; IN VITRO SELECTION; LEUKOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SPLEEN CELL;

MUS;

EID: 48949119139     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2008.05.004     Document Type: Article

References (37)

1. Engel R.R., and Smith A.H. Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 49 (1994) 418-427
2. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol Appl Pharmacol 176 (2001) 127-144
3. Flora S.J. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol 26 (1999) 865-869
4. Chen A., Cao E.H., Zhang T.C., and Qin J.F. Arsenite-induced reactive oxygen species and the repression of alpha-tocopherol in the MGC-803 cells. Eur J Pharmacol 448 (2002) 11-18
5. Patel R.P., Moellering D., Murohy-Ullrich J., Jo H., Becman J.S., and Darley-Usmar V.M. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Rad Biol Med 28 (2000) 1780-1794
6. Ley K., and Tedder T.F. Leukocyte interactions with vascular endothelium: new insight into selectin-mediated attachment and rolling. J Immunol 155 (1995) 525-528
7. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
8. Henderson R.B., Lim L.H.K., Tessier P.A., Gavins F.N.E., Mathies M., Perretti M., et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1 and α4 integrin in the inflammatory response of neutrophils. J Exp Med 194 (2001) 219-226
9. Nolte D., Kuebler W.M., Muller W.A., Wolff K.D., and Messmer K. Attenuation of leukocyte sequestration by selective blockade of PECAM-1 or VCAM-1 in murine endotoxemia. Eur Surg Res 36 (2004) 331-337
10. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., and Springer T.A. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). I Immunol 137 (1986) 245-254
11. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., et al. Shock and tissue injury induced by recombinant human cachectin. Science 234 (1986) 470-474
12. Calder P.C. Glutamine and the immune system. Clin Nutr 13 (1994) 2-8
13. Wilmore D.W., and Shabert J.K. Role of glutamine in immunologic responses. Nutrition 14 (1998) 618-626
14. Hammerquist F., Wernerman J., Al R., Vonder D., and Vinners E. Addition of glutamine to total parenteral nutrition after elective abdominal surgery spares glutamine in muscle, counteracts the fall in muscle protein synthesis and improves nitrogen balance. Ann Surg 209 (1989) 455-461
15. Gianotti L., Alexander J.W., Gennari R., Pyles T., and Babcock G.F. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. J Parenter Enter Nutr 19 (1995) 69-74
16. Parry-Billings M., Evans J., Calder P.C., and Newsholme E.A. Does glutamine contribute to immunosuppression after major burns?. Lancet 336 (1990) 523-525
17. Willmore D.W. The effects of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 131 (2001) 2543-9S
18. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., and Chang E.B. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 16 (2001) 398-402
19. Arndt H., Kullmann F., Reuss F., Scholmerich J., and Palitzsch K.D. Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat. J Parenter Enter Nutr 23 (1999) 12-18
20. Smith R.J., and Panico K. Automated analysis of o-phthalaldehyde derivatives of amino acids in physiological fluids of reverse phase high performance liquid chromatography. J Liq Chromatogr 8 (1985) 1783-1795
21. Meier U. A note on the power of Fisher's least significant difference procedure. Pharm Stat 5 (2006) 253-263
22. Waalkes M.P., Ward J.M., and Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestation exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure to hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25 (2004) 133-141
23. Simeonova P.P., Hulderman T., Harki D., and Luster M.I. Arsenic exposure accelerates atherogenesis in apoprotein E-/- mice. Environ Health Persp 111 (2003) 1744-1748
24. Samikkannu T., Chen C.H., Yih L.H., Wang A.S., Lin S.Y., Chen T.C., et al. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem Res Toxicol 16 (2003) 409-414
25. Navas-Acien A., Silbergeld E.K., Streeter R.A., Clark J.M., et al. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspec 114 (2006) 641-648
26. Wang S.L., Chang F.H., Liou S.H., Wang H.J., Li W.F., and Hsieh D.P.H. Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ Int 33 (2007) 805-811
27. Heck J.E., Chen Y., Grann V.R., Slavkovich V., Parvez F., and Ahsan H. Arsenic exposure and anemia in Bangladesh: a population-based study. J Occup Environ Med 50 (2008) 80-87
28. Plow E.F., and Zhang L. A Mac-1 attack: integrin functions directly challenged in knockout mice. J Clin Invest 99 (1997) 1145-1146
29. Albelda S.M., Smith C.W., and Ward P.A. Adhesion molecules and inflammatory injury. FASEB J 8 (1994) 504-512
30. Rahimi K., Macrz H.K., Zotz R.J., and Tarnok A. Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease. Cytometry 53B (2003) 63-69
31. Hou Y.C., Hsu C.S., Yeh C.L., Chiu W.C., Pai M.H., and Yeh S.L. Effects of glutamine on adhesion molecule expression and leukocyte transmigration in endothelial cells exposed to arsenic. J Nutr Biochem 16 (2005) 700-704
32. Cruickshank A.M., Fraser W.D., Burns H.J.G., Van Dame J., and Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery with varying intensities. Clin Sci 79 (1990) 161-165
33. Yeh C.L., Yeh S.L., Lin M.T., and Chen W.J. Effects of arginine-enriched total parenteral nutrition on inflammatory-related mediator and T cell population in septic rats. Nutrition 18 (2002) 631-635
34. DiPiro J.T. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 17 (1997) 205-223
35. Rohde T., Maclean D.A., and Pedersen B.K. Glutamine, lymphocyte proliferation and cytokine production. Scand J Immunol 44 (1996) 648-650
36. Hong R.W., Rounds J.D., Helton W.S., Robinson M.K., and Wilmore D.W. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215 (1992) 114-119
37. Welbourne T.C. Ammonia production and GLN incorporation into GSH in the functioning rat kidney. Can J Biochem 57 (1979) 233-237